News
The biopharmaceutical company AstraZeneca announced it will $50 billion into the United States, with plans to open several ...
The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...
With the threat of tariffs looming for medicines imported to the United States, AstraZeneca has unveiled a plan to invest $50 ...
UK-based pharmaceutical giant AstraZeneca plans to build its largest drug manufacturing facility in Virginia, creating ...
AstraZeneca, a pharmaceutical company, has announced its plans to bring a drug substance manufacturing facility to Virginia.
Virginia facility investment will be AstraZeneca’s largest yet. Maryland, Massachusetts, California, Indiana, Texas projects ...
British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump ...
British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid Donald ...
AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...
The pharmaceutical company is accelerating its expansion in the country as President Donald Trump considers tariffs of up to ...
AstraZeneca plans to construct a multi-billion dollar manufacturing center focused on chronic diseases in Virginia within the next five years.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results